Showing 9511-9520 of 18560 results for "".
- Integrating Oncology and Dermatology: Addressing ICI-Induced Psoriasis Riskhttps://reachmd.com/news/integrating-oncology-and-dermatology-addressing-ici-induced-psoriasis-risk/2475860/The integration of oncology and dermatology is increasingly important as immune checkpoint inhibitors (ICIs) transform cancer care and elevate psoriasis risk among survivors. Clinicians now face an unexpected challenge: the introduction of
- AI's Evolving Role in Radiology: Balancing Innovation with Cautionhttps://reachmd.com/news/ais-evolving-role-in-radiology-balancing-innovation-with-caution/2475863/In radiology departments worldwide, while artificial intelligence algorithms enhance diagnostic precision and efficiency, challenges such as data privacy and model biases remain significant barriers. The proliferation of AI-driven solutions has led to 173 products entering clinical r
- Addressing the Global Burden of Interstitial Lung Diseases and Pulmonary Sarcoidosishttps://reachmd.com/news/addressing-the-global-burden-of-interstitial-lung-diseases-and-pulmonary-sarcoidosis/2475867/Clinicians are increasingly grappling with interstitial lung diseases, including pulmonary sarcoidosis, that impact global health resources significantly. Current research shows a steady
- Overcoming Therapeutic Inertia in Metastatic Castration-Resistant Prostate Cancer with Radium-223https://reachmd.com/news/overcoming-therapeutic-inertia-in-metastatic-castration-resistant-prostate-cancer-with-radium-223/2475881/Overcoming therapeutic inertia in metastatic castration-resistant prostate cancer demands a paradigm shift, and consideration of early integration of Radium-223 into the treatment algorithm can be informed by
- Gene Therapy's Promise in Inherited Retinal Diseaseshttps://reachmd.com/news/gene-therapys-promise-in-inherited-retinal-diseases/2475876/Gene therapy for inherited retinal diseases (IRDs) is reaching a tipping point where targeted genetic corrections could shift decades-old paradigms of vision loss management. Inherited retinal diseases affect approximately one in 2,000 individuals and pose a formidable clinical chall
- Unlocking the Potential of Autoantibodies in Cancer Immunotherapyhttps://reachmd.com/news/unlocking-the-potential-of-autoantibodies-in-cancer-immunotherapy/2475879/Advancements in personalized medicine and immunotherapy are opening new possibilities in cancer treatment. However, predicting which patients will respond remains challenging. Autoantibodies have become important indicators of patient response, and ensuring that engineered immune cells rema
- Innovative Disease Modeling in Alzheimer’s: A New Frontier in Diagnosis and Treatmenthttps://reachmd.com/news/innovative-disease-modeling-in-alzheimers-a-new-frontier-in-diagnosis-and-treatment/2475864/Alzheimer’s disease modeling is unlocking unprecedented insight into tau protein propagation and genetic vulnerability, offering a transformative lens for diagnosis and therapy. Neurologists face a pressing challenge: the uneven spread of neurofibrillary tangles and tau protein acros
- Emerging Innovations in Neonatal Care: Transforming Outcomes for Preterm Infantshttps://reachmd.com/news/emerging-innovations-in-neonatal-care-transforming-outcomes-for-preterm-infants/2475868/Emerging Innovations in Neonatal Care: Transforming Outcomes for Preterm Infants The incidence of respiratory distress syndrome in preterm infants varies significantly with gestational age, for example, 98% at 24 weeks, which has led to the rapid adoption of non-invasive hi
- Advancing Breast Conserving Surgery with Innovative Techniqueshttps://reachmd.com/news/advancing-breast-conserving-surgery-with-innovative-techniques/2475870/Achieving precise resection margins and integrating preventive measures have emerged as pivotal challenges for surgical oncology teams striving to optimize breast conserving surgery and reduce recurrence. Despite advancements in breast cancer surgery techniques, standard approaches t
- Overcoming X Inactivation Challenges in Rett Syndromehttps://reachmd.com/news/overcoming-x-inactivation-challenges-in-rett-syndrome/2475839/For pediatric neurologists and clinical geneticists, overcoming the challenges of X inactivation has long blocked the development of disease-modifying treatments for Rett syndrome, leaving care focused on symptomatic relief rather than addressing the underlying genetic cause.